Vadodara‑based Kronox Lab Sciences Ltd, a fine‑chemicals manufacturer that debuted on the stock exchanges in 2024, is set to change hands just two years later. The company’s founding promoters have agreed to sell 64.26% of their stake to Indo Borax & Chemicals Ltd. for Rs. 246 crore, marking a shift in management and control and positioning Indo Borax to diversify beyond its core boron‑based chemicals business.
Mumbai-based Indo Borax, along with its promoter Zenrock Chemicals Pvt. Ltd., signed a share purchase agreement to acquire the stake. According to Kronox’s regulatory filing, its promoters – Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani and Jogindersingh Gianchand Jaswal – will sell 2.38 crore shares at Rs. 103.22 apiece, reducing their collective holding from 74.21% to 9.95%, which will remain locked in for a specified period and subject to Indo Borax’s right of first refusal thereafter.
The acquisition triggers a mandatory open offer under takeover regulations. Indo Borax, along with Zenrock Chemicals as a person acting in concert, will make an offer to acquire up to 95.7 lakh shares, representing 25.79% of Kronox’s equity. If fully subscribed, the open offer could further increase the combined holding of Indo Borax and Zenrock. Neither company currently holds shares in Kronox, and both are unrelated to the existing promoter group.
Change in board composition
Indo Borax will appoint three nominee directors to Kronox’s board, while the existing promoters will step down as directors once the deal closes. They will, however, continue to support the transition through consultancy agreements.
Mr. Suresh Kalra, Managing Director and CEO of Indo Borax, said the acquisition marked the beginning of a new chapter for the company, adding that it was committed to creating stakeholder value through expansion, diversification, premiumisation and margin improvement.
Kronox Lab Sciences manufactures high-purity speciality fine chemicals, including excipients, reagents, buffers and intermediates, for the pharmaceutical, nutraceutical, biotechnology, agrochemical, scientific research, laboratory testing, metallurgy and personal care industries. The company has a portfolio of more than 185 products, multiple manufacturing facilities in Gujarat, and a presence in domestic and export markets. It reported Rs. 101-crore in revenue and Rs. 28-crore in PAT in FY26.
Indo Borax manufactures boric acid, disodium octaborate tetrahydrate and borax at its plant in Pithampur, Madhya Pradesh.


25 August, 2026 16:40:32 IST 

















